HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma. - Wikidata - wikimedia - TriplyDB

HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.

HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q37599574

about

The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1 Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3.Investigational therapies targeting the ErbB family in oesophagogastric cancer.EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.Pertuzumab in gastrointestinal cancer.Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas.

P2860

Q28069924-6969EA90-65F0-4765-8640-95B95C4313D3 Q28077666-13CAC2ED-53CA-479D-B271-ED765783C438 Q35845600-0151C119-4D04-462D-99AC-5F85563619E8 Q36547753-B6E56D13-4120-4C72-BCD8-6649767E06C0 Q36962935-E6A92709-BC56-4A4B-BE22-A943947CC39A Q38221886-9CEA28C5-64F3-4A00-B156-DDDBFB4ACE1B Q38392935-36F0B150-CF5A-4B68-8EDF-009815CDCD81 Q38653309-78ED6D7F-AA7A-4E14-A564-06B850A45DE9 Q42717966-268BF97C-C6EA-4BFB-AE73-FF6B4B9261EA

P2860

HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q37599574

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@en

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@nl

type

label

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@en

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@nl

prefLabel

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@en

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@nl

P1433

Q37599574-4404A54C-FE75-4D94-9C71-396E9013F16B

P1476

Q37599574-1D815012-2759-456A-813C-E819E2504AD0

P2093

Q37599574-1B2389FC-72AB-484D-86E6-360FEAA3233C

Q37599574-4F3F2EDE-252E-4825-AB83-32E1B86C7CEF

Q37599574-516AE321-700C-4BEA-8E50-9CF1545D891C

Q37599574-6CC8534B-7FFB-4A97-A474-E3DF42CCB957

Q37599574-6E658DEF-60DD-4EBA-9C10-DF81BF9E8FC0

Q37599574-88868C6E-997E-46B0-B4BA-16868689547D

Q37599574-9BD43507-5F51-4D8B-8DE2-69E79C036D77

Q37599574-D4F9137A-8C9E-4ADB-B026-5EC02351C4CE

Q37599574-EBCA1EE6-B1BF-4DC3-91B4-45691F110BB0

P2860

Q37599574-034CC070-4EC4-4B43-A21B-716F23F6B31C

Q37599574-09A7B0EB-5BBB-4B5E-A05B-42E11607F62D

Q37599574-1045331A-2225-4170-9F75-5FC13D2C6145

Q37599574-24CF9DEA-EDF0-4A16-B791-905E1219F12E

Q37599574-24E6E4DE-A18C-42D6-B676-9C6B72071F97

Q37599574-2AC714ED-761F-4B3E-95E0-AAC0CA1A19EB

Q37599574-32B5F170-C6E5-427C-97DF-7F22384E645E

Q37599574-3600C503-EAE9-45FF-AFCA-3A518E41D0C1

Q37599574-3D1FE2E5-276B-4F6F-99E2-16976CCB61EC

Q37599574-415CC552-011B-4545-ACEF-4A8FC7782BDA

P304

Q37599574-4303C7E3-EC57-4415-84C9-C3C6C5147196

P31

Q37599574-33916A16-3ADE-4D09-A273-3B71DC558303

P356

Q37599574-CCDC08B0-018D-41CB-99EB-8DAE15781386

P407

Q37599574-26D62C9D-1177-4086-8D74-B748B17318E8

P433

Q37599574-36B08B80-2744-4AFD-AF63-B3C58D17E2EC

P478

Q37599574-C7F70FA6-D9AB-40C9-8087-EB3F14B287B9

P577

Q37599574-2988AAAF-BA03-4062-AC52-EE024D5B56D2

P5875

Q37599574-339EEFF8-9D52-4AA8-A696-77890CC2567F

P698

Q37599574-431B6945-8C3D-4F88-912E-545ABFCF6503

P921

Q37599574-687069BA-0BD7-47E5-973E-C475EFA824B3

P932

Q37599574-90A03640-7FA5-4650-8411-3A0CCE98B23A

P356

P1433

P1476

HER-2/neu gene amplification i ...... ith esophageal adenocarcinoma.

@en

P2093

Anne E Wiktor

http://www.w3.org/2001/XMLSchema#string

Christopher A Sattler

http://www.w3.org/2001/XMLSchema#string

Frank A Sinicrope

http://www.w3.org/2001/XMLSchema#string

Harry H Yoon

http://www.w3.org/2001/XMLSchema#string

Qian Shi

http://www.w3.org/2001/XMLSchema#string

Robert B Diasio

http://www.w3.org/2001/XMLSchema#string

Robert B Jenkins

http://www.w3.org/2001/XMLSchema#string

Tsung-Teh Wu

http://www.w3.org/2001/XMLSchema#string

William R Sukov

http://www.w3.org/2001/XMLSchema#string

P2860

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

HER2 testing in gastric cancer: a practical approach

Molecular classification of gastric cancer: a new paradigm.

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.

The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.

Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

P304

415-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28435

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258037160

http://www.w3.org/2001/XMLSchema#string

P698

24151090

http://www.w3.org/2001/XMLSchema#string

P921

P932

3932765

http://www.w3.org/2001/XMLSchema#string